DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Raut CP, Espat NJ, Maki RG, Araujo DM, Williams TF, Wolff JE. et al.
Extended treatment with adjuvant imatinib (IM) for patients (pts) with high-risk primary gastrointestinal stromal tumor (GIST): The PERSIST-5 study.
J Clin Oncol 2017;
35 Suppl 15: 11009
Access:
We do not assume any responsibility for the contents of the web pages of other providers.